Tags: 
SCIO Strategic Consulting
The Strategic Clinical Innovation Organization (SCIO) concept provides biotech, pharmaceutical and device companies with a cost-effective, customized approach to clinical development. This approach, pioneered by BBCR, reduces the risks of clinical development.
The changing regulatory expectations require greater precision in clinical development, from the outset of the early stage. The SCIO concept, pioneered by BBCR, provides:
- An early roadmap, to visualize goals, action plans and options
- A strategic clinical plan concurrent with a regulatory strategy
- Expert support on selection of indications
- Optimized patient selection
- Support management decision making
The SCIO concept is a bridge:
- Translating preclinical data into market opportunities
- Connecting product potential with actual treatment benefits
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.